|
MegaPro Biomedical was invited to “The Third China BioMed Innovation and Investment Conference” hosted by PhIRDA
|
2018-09-14 |
|
MegaPro Biomedical was invited to participate in the "3rd China Pharmaceutical Innovation and Investment Conference" hosted by China Pharmaceutical industry Research and Development Association
|
2018-09-14 |
|
Outstanding performance from MegaPro Biomedical, the contrast agent has received approval by FDA for Phase II of clinical trial
|
2018-02-09 |
|
MegaPro Biomedical has performed brilliantly, and the rapid development process of the developer product has been approved by the US FDA to enter the clinical phase II trial
|
2018-02-09 |
